Breaking News Instant updates and real-time market news.

VCYT

Veracyte

$26.18

1.52 (6.16%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09

Veracyte announces preliminary nasal swab test clinical data

Veracyte announced preliminary clinical data showing that the company's noninvasive nasal swab test can enable early lung cancer detection and diagnosis. The new findings specifically show that the novel genomic test can accurately classify lung cancer risk in patients with lung nodules so that these patients can obtain the prompt diagnosis and potential treatment they need or may be monitored noninvasively. The findings will be presented at the annual meeting of the American College of Chest Physicians. To develop and evaluate the test, Veracyte utilized nasal samples from over 700 patients with lung nodules found on computed tomography, or CT, scans who were prospectively recruited and whose cancer status was subsequently determined. The researchers evaluated the test's performance on an independent blinded subset of 261 patients. The researchers determined the genomic test's ability to identify patients as high risk and low risk for cancer and then modeled its impact on patient care when the cancer prevalence is 25%. This aligns with the anticipated cancer prevalence among the people on whom the test will eventually be used. Among patients whose nodules were benign, the genomic test classified over 40% as low risk for cancer, with a sensitivity of over 95%, meaning that these patients could be monitored noninvasively with a low chance of missing a cancer. Among patients whose nodules were malignant, the test classified over 40% as high risk for cancer, with a specificity of over 94%, meaning these patients could be directed to more invasive diagnostic procedures and treatment, with a low rate of false positive results. The test's performance was consistent regardless of lung nodule size or location, as well as cancer subtype or stage. Currently, physicians use clinical factors to calculate the risk of cancer when a lung nodule is found. However, these calculators vary widely in how they measure risk, produce differing results and have in some cases been shown to be less accurate than physician judgment alone. Researchers in the current study determined that the nasal swab test would identify over 70% more patients as "low risk" and 18% more patients as "high risk," as compared to one of the most widely used clinical risk calculators.

  • 22

    Oct

  • 12

    Dec

VCYT Veracyte
$26.18

1.52 (6.16%)

07/02/19
NEED
07/02/19
INITIATION
Target $33
NEED
Buy
Veracyte initiated with a Buy at Needham
Needham analyst Stephen Unger started Veracyte with a Buy rating and $33 price target. The company has "significant potential for meaningful" long-term revenue growth as its advanced diagnostic tests that improve patient outcomes, while also reducing diagnostic costs, commercializes, Unger tells investors in a research note. The analyst believes Veracyte's Afirma Gene Expression Classifier is a well established test used by U.S. physicians to improve the diagnosis of thyroid nodules.
07/02/19
07/02/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Veru (VERU) initiated with an Overweight at Cantor Fitzgerald. 2. Uber (UBER) initiated with a Hold at Stifel. 3. Wyndham Hotels & Resorts (WH) initiated with an Overweight at Barclays. 4. Veracyte (VCYT) initiated with a Buy at Needham. 5. Paysign (PAYS) initiated with a Buy at Canaccord. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/31/19
LSCM
07/31/19
INITIATION
Target $35
LSCM
Buy
Veracyte initiated with a Buy at Lake Street
Lake Street analyst Thomas Flaten started Veracyte with a Buy rating and $35 price target. Veracyte can expand its offering to improve decision-making across the patient care continuum by leveraging its technology and bioinformatics platforms to develop and commercialize new product offerings, Flaten tells investors in a research note. He believes the company's late 2019 nasal swab test data for lung cancer "could further validate this evolution."
07/31/19
07/31/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Verra Mobility (VRRM) initiated with a Neutral at Goldman Sachs. 2. Myomo (MYO) initiated with a Buy at Ascendiant. 3. Chiasma (CHMA) initiated with an Overweight at Piper Jaffray. 4. IAA (IAA) initiated with a Buy at Jefferies. 5. Veracyte (VCYT) initiated with a Buy at Lake Street. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SSRM

SSR Mining

$14.72

0.22 (1.52%)

04:52
11/13/19
11/13
04:52
11/13/19
04:52
Upgrade
SSR Mining rating change  »

SSR Mining upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LSGOF

Land Securities Group

$0.00

(0.00%)

04:49
11/13/19
11/13
04:49
11/13/19
04:49
Downgrade
Land Securities Group rating change  »

Land Securities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:00
11/13/19
11/13
04:00
11/13/19
04:00
General news
FX Action: USD-CAD has posted a fresh one-month peak »

FX Action: USD-CAD has…

02:50
11/13/19
11/13
02:50
11/13/19
02:50
General news
FX Update: The New Zealand dollar surged by over 1% »

FX Update: The New…

01:55
11/13/19
11/13
01:55
11/13/19
01:55
General news
Asian Market Update: »

Asian Market Update:…

01:55
11/13/19
11/13
01:55
11/13/19
01:55
General news
U.S. CPI preview: analysts're forecasting a »

U.S. CPI preview:…

01:30
11/13/19
11/13
01:30
11/13/19
01:30
General news
Fed's Kashkari now a little more optimistic on the U.S. economy »

Fed's Kashkari now a…

WSM

Williams-Sonoma

$70.48

-0.88 (-1.23%)

21:33
11/12/19
11/12
21:33
11/12/19
21:33
Initiation
Williams-Sonoma initiated at Barclays »

Williams-Sonoma initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$84.57

1.28 (1.54%)

21:31
11/12/19
11/12
21:31
11/12/19
21:31
Initiation
Wayfair initiated at Barclays »

Wayfair initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

VFC

VF Corp.

$84.69

-1.7 (-1.97%)

21:28
11/12/19
11/12
21:28
11/12/19
21:28
Initiation
VF Corp. initiated at Barclays »

VF Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$30.85

0.295 (0.97%)

21:25
11/12/19
11/12
21:25
11/12/19
21:25
Initiation
Urban Outfitters initiated at Barclays »

Urban Outfitters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

UAA

Under Armour

$17.29

-0.295 (-1.68%)

21:23
11/12/19
11/12
21:23
11/12/19
21:23
Initiation
Under Armour initiated at Barclays »

Under Armour initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTA

Ulta Beauty

$244.06

2.19 (0.91%)

21:19
11/12/19
11/12
21:19
11/12/19
21:19
Initiation
Ulta Beauty initiated at Barclays »

Ulta Beauty initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

TJX

TJX

$58.40

-0.14 (-0.24%)

21:15
11/12/19
11/12
21:15
11/12/19
21:15
Initiation
TJX initiated at Barclays »

TJX initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

TPR

Tapestry

$26.38

-0.295 (-1.11%)

21:12
11/12/19
11/12
21:12
11/12/19
21:12
Initiation
Tapestry initiated at Barclays »

Tapestry initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

AFL

Aflac

$53.97

-0.04 (-0.07%)

21:02
11/12/19
11/12
21:02
11/12/19
21:02
Hot Stocks
Aflac names Frederick Crawford new COO »

Aflac announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROST

Ross Stores

$110.97

-1.16 (-1.03%)

21:00
11/12/19
11/12
21:00
11/12/19
21:00
Initiation
Ross Stores initiated at Barclays »

Ross Stores initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

RL

Ralph Lauren

$111.44

-2.58 (-2.26%)

20:57
11/12/19
11/12
20:57
11/12/19
20:57
Initiation
Ralph Lauren initiated at Barclays »

Ralph Lauren initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$174.48

-0.18 (-0.10%)

20:56
11/12/19
11/12
20:56
11/12/19
20:56
Initiation
RH initiated at Barclays »

RH initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVH

PVH Corp.

$96.91

0.14 (0.14%)

20:53
11/12/19
11/12
20:53
11/12/19
20:53
Initiation
PVH Corp. initiated at Barclays »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

JWN

Nordstrom

$36.90

-0.52 (-1.39%)

20:51
11/12/19
11/12
20:51
11/12/19
20:51
Initiation
Nordstrom initiated at Barclays »

Nordstrom initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NKE

Nike

$89.51

-0.52 (-0.58%)

20:46
11/12/19
11/12
20:46
11/12/19
20:46
Initiation
Nike initiated at Barclays »

Nike initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EYE

National Vision

$27.03

0.24 (0.90%)

20:43
11/12/19
11/12
20:43
11/12/19
20:43
Initiation
National Vision initiated at Barclays »

National Vision initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$17.53

0.02 (0.11%)

20:40
11/12/19
11/12
20:40
11/12/19
20:40
Initiation
L Brands initiated at Barclays »

L Brands initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BABA

Alibaba

$186.97

0.26 (0.14%)

20:25
11/12/19
11/12
20:25
11/12/19
20:25
Periodicals
Alibaba gets approval to sell shares in Hong Kong, SCMP reports »

Alibaba has received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.